Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
High Hiv Prevalence in a Respondent-Driven Sampling Survey of Injection Drug Users in Tehran, Iran Publisher Pubmed



Malekinejad M1, 2 ; Mohraz M3 ; Razani N4 ; Akbari G3 ; Mcfarland W5 ; Khairandish P3 ; Malekafzali H6 ; Gouya MM7 ; Zarghami A8 ; Rutherford GW2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Institute for Health Policy Studies, University of California, 3333 California Street, Suite 265, San Francisco, 94118, CA, United States
  2. 2. Global Health Sciences, University of California, San Francisco, United States
  3. 3. Iranian Research Center for HIV and AIDS, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Division of General Pediatrics, School of Medicine, University of California, San Francisco, United States
  5. 5. San Francisco Department of Public Health, San Francisco, United States
  6. 6. Department of Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Center for Disease Management, Iranian Ministry of Health and Medical Education, Tehran, Iran
  8. 8. Santa Clara County Public Health Department, Santa Clara, United States

Source: AIDS and Behavior Published:2015


Abstract

Iran is facing unprecedented dual drug use and HIV epidemics. We conducted a cross-sectional survey to obtain HIV prevalence and risk behavior data from injection drug users (IDU) in Tehran. We used respondent-driven sampling (RDS) to recruit IDU through successive waves starting with 24 “seeds,” conducted anonymous face-to-face interviews and HIV testing and counseling, and used RDSAT to adjust data. During 44 weeks, 1,726 study referral coupons resulted in 645 (37 %) IDU referrals, of whom 548 (85 %) were enrolled. From those enrolled, 84 % were incarcerated, 47 % employed, 55 % single, 27 % under 30 years of age, and 26 % homeless. The adjusted HIV prevalence was 26.6 % (95 % confidence interval 21.3–32.1), and was higher among certain IDU subgroups (e.g., those who sharing injection paraphernalia). Our estimates of HIV prevalence were higher than some other estimates; however, repeated surveys using similar methodology are needed to monitor the trend of HIV epidemic over time. © 2014, Springer Science+Business Media New York.
Other Related Docs
22. Hiv-Related Risk Behaviors Among Male Inmates of Tehran, Iran, Asian Pacific Journal of Tropical Disease (2016)